BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

FDA Panel To Weigh Painkiller' Cardiac Risk


2/10/2014 7:39:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A Food and Drug Administration panel could soon help determine the fate of billions of dollars in household-name pain drugs such as Advil and Aleve over the question of which ones pose a greater cardiac risk. An advisory committee of medical experts is expected to spend two days this week reaching a recommendation on whether the drug naproxen, sold as Aleve by Bayer AG BAYN.XE +0.32% , may carry little to no heart danger, giving it a possible boost over other anti-inflammatory drugs. Aleve and other medicines, such as the prescription drug Celebrex and ibuprofen, sold under the brands Advil and Motrin and in generic versions, are used by millions of people for joint pain, arthritis and a range of aches and injuries.

Help employers find you! Check out all the jobs and post your resume.



   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES